Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells-Reference-Cited by-同舟云学术

Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells

Published:2022-04 Issue: Volume:819 Page:146246
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Morales Fernanda,Pérez Paola,Tapia Julio C.,Lobos-González Lorena,Herranz José Manuel,Guevara Francisca,de Santiago Pamela Rojas,Palacios Esteban,Andaur Rodrigo,Sagredo Eduardo A.,Marcelain Katherine,Armisén Ricardo

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference73 articles.

1. Glycogen synthase kinase 3 missplicing contributes to leukemia stem cell generation;Abrahamsson;Proc. Natl. Acad. Sci.,2009

2. The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizingFAK;Amin;Sci. Signaling,2017

3. GSK3alpha exhibits beta-catenin and tau directed kinase activities that are modulated by Wnt;Asuni;Eur. J. Neurosci.,2006

4. Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome;Athanasiadis;PLoS Biol.,2004

5. Accurate identification of A-to-I RNA editing in human by transcriptome sequencing;Bahn;Genome Res.,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer;International Journal of Molecular Sciences;2024-07-06

2. A Comprehensive Analysis of the Effect of A>I(G) RNA-Editing Sites on Genotoxic Drug Response and Progression in Breast Cancer;Biomedicines;2024-03-25

3. ADAR1 affects gastric cancer cell metastasis and reverses cisplatin resistance through AZIN1;Anti-Cancer Drugs;2023-04-28

4. Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks;International Journal of Biological Macromolecules;2023-03

5. ADAR1 and its implications in cancer development and treatment;Trends in Genetics;2022-08